# AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

> **NCT00359112** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 544 (—)

## Conditions studied

- Non-Insulin-Dependent Diabetes Mellitus

## Interventions

- **DRUG:** metformin
- **DRUG:** sulphonylurea
- **DRUG:** Avandamet

## Key facts

- **NCT ID:** NCT00359112
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 544 (—)
- **Last updated:** 2009-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00359112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00359112, "AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00359112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*